Tetanus
📧 Sign up to get email alerts when something new happens for Tetanus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-04-18Clinical Trial Update: Immunogenicity and Safety of Boostrix Polio Vaccine as a Booster Dose in 5 to 6-year-old Children. [Phase 3]
Phase 3 trial evaluating the immunogenicity and safety of Boostrix Polio as a booster dose in 5- to 6-year-old children; results have been p…
-
CLINICAL_TRIALS trial_result · 2017-04-14Clinical Trial Update: Immunogenicity and Safety Study of GSK Biologicals' GSK2202083A Vaccine in Healthy Infants at 2, 3 and 4 Months of Age [Phase 2]
Phase 2 immunogenicity and safety study of GSK's GSK2202083A vaccine in healthy infants aged 2, 3, and 4 months completed.
-
CLINICAL_TRIALS trial_result · 2017-04-13Clinical Trial Update: Immunogenicity and Safety Study of Booster Dose of GSK Biologicals' IPV (Poliorix™) and DTPa/Hib (Infanrix+Hib™) Vaccine [Phase 3]
A Phase 3 immunogenicity and safety study evaluating a booster dose of GSK's Poliorix (IPV) and Infanrix+Hib (DTPa/Hib) has completed with r…
-
CLINICAL_TRIALS trial_result · 2017-04-12Clinical Trial Update: Study to Evaluate the Immunogenicity and Reactogenicity of a Booster Dose of GSK2036874A Vaccine in Healthy Toddlers [Phase 2]
Phase 2 trial assessing immunogenicity and reactogenicity of a booster dose of GSK2036874A vaccine in healthy toddlers; study completed with…
-
CLINICAL_TRIALS trial_result · 2017-04-11Clinical Trial Update: Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine Administered as a Booster Dose [Phase 2]
Phase 2 immunogenicity and safety study of GlaxoSmithKline's GSK2202083A vaccine given as a booster; completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-04-10Clinical Trial Update: Immunogenicity and Safety Study of GSK Biologicals' Infanrix-IPV+Hib™ Vaccine [Phase 3]
Phase 3 immunogenicity and safety study of GSK's Infanrix-IPV+Hib vaccine completed with results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-04-10Clinical Trial Update: Safety Study of GSK Biologicals' DTPa-IPV/Hib (Infanrix™-IPV/Hib) [Phase 3]
Phase 3 safety study of GSK's DTPa-IPV/Hib vaccine (Infanrix-IPV/Hib) has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2017-04-04Clinical Trial Update: Feasibility Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine in Healthy Infants at 3, 5 and 11 Months of Age. [Phase 2]
Phase 2 feasibility study of GSK's GSK2202083A vaccine in healthy infants at 3, 5, and 11 months was terminated, with results posted in 2017…
-
CLINICAL_TRIALS trial_result · 2017-03-30Clinical Trial Update: Immunogenicity & Reactogenicity of Boostrix 10 Years After Previous Booster Vaccination. [Phase 4]
A Phase 4 study evaluated the immunogenicity and safety (reactogenicity) of Boostrix administered 10 years after a prior booster, in individ…
-
CLINICAL_TRIALS trial_result · 2017-03-29Clinical Trial Update: Safety Study of Tritanrix-HepB/Hib-MenAC, Tritanrix-HepB/Hiberix, and Mencevax ACWY Vaccines in Children [Phase 3]
Phase 3 safety study results completed for combination vaccines Tritanrix-HepB/Hib-MenAC, Tritanrix-HepB/Hiberix, and Mencevax ACWY in child…
-
CLINICAL_TRIALS trial_result · 2017-03-16Clinical Trial Update: US-licensed Combined Vaccine Against Tetanus & Diphtheria, Given With US-licensed Vaccine Against Meningococcal Disease [Phase 4]
Phase 4 trial update on US-licensed combined tetanus, diphtheria, and meningococcal vaccines; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2017-02-28Clinical Trial Update: Immune Memory of DTPw-HBV/Hib Vaccine Following Primary Vaccination, Immuno & Reacto of a Booster Dose Given in Infants [Phase 3]
Phase 3 clinical trial update assessing immune memory and reactogenicity of the DTPw-HBV/Hib pentavalent vaccine in infants, including respo…
-
CLINICAL_TRIALS trial_result · 2017-02-10Clinical Trial Update: Study to Assess Safety & Immunogenicity of GSK Biologicals' DTPa/Hib Vaccine vs Separate Administration of DTPa and Hib. [Phase 3]
Phase 3 trial evaluating safety and immunogenicity of GSK's DTPa/Hib vaccine compared with separate DTPa and Hib administration; the study i…
-
CLINICAL_TRIALS trial_result · 2017-02-07Clinical Trial Update: Safety of DTPa-IPV/Hib & DTPa-HBV-IPV/Hib, Followed by DTPa-IPV/Hib Vaccine in Infants Who Received Hepatitis B Vaccine [Phase 3]
A Phase 3 study evaluated the safety of two combination vaccines (DTPa-IPV/Hib and DTPa-HBV-IPV/Hib) in infants who had received hepatitis B…
-
CLINICAL_TRIALS trial_result · 2017-02-07Clinical Trial Update: Assess the Safety & Reactogenicity of DTPa-IPV/Hib Vaccine Administered at 3, 4, 5 & 18 Mths of Age, in Healthy Infants [Phase 4]
Phase 4 trial updating safety and reactogenicity of DTPa-IPV/Hib vaccine administered at 3, 4, 5 and 18 months in healthy infants; completed…
-
CLINICAL_TRIALS trial_result · 2017-01-04Clinical Trial Update: Post Marketing Surveillance for ADACEL™ in South Korea [Phase 4]
Phase 4 post-marketing surveillance study for ADACEL™ in South Korea evaluating diphtheria, tetanus, and pertussis in real-world use; study …
-
CLINICAL_TRIALS trial_result · 2017-01-04Clinical Trial Update: Regulatory Post-Marketing Surveillance Study for TETRAXIM™ [Phase 4]
Phase 4 post-marketing surveillance study for TETRAXIM. The trial completed and results were posted in 2017.
-
CLINICAL_TRIALS trial_result · 2016-12-29Clinical Trial Update: Study to Evaluate Antibody Persistence in Children Previously Vaccinated With Infanrix Hexa™ or Infanrix-IPV/Hib™ [Phase 4]
Phase 4 study assessing antibody persistence in children previously vaccinated with Infanrix Hexa or Infanrix-IPV/Hib; completed with result…
-
CLINICAL_TRIALS trial_result · 2016-12-12Clinical Trial Update: Safety of a Booster Dose of GlaxoSmithKline (GSK) Biologicals' Boostrix™ Vaccine in Healthy Vietnamese Children [Phase 3]
Phase 3 trial update assessing safety of a booster dose of Boostrix vaccine in healthy Vietnamese children; results posted in 2016. Conditio…
-
CLINICAL_TRIALS trial_result · 2016-11-30Clinical Trial Update: Immunogenicity and Safety of GSK Biologicals' Infanrix Hexa in Infants [Phase 4]
Phase 4 trial update on immunogenicity and safety of Infanrix Hexa in infants, with results posted after completion.
-
CLINICAL_TRIALS trial_result · 2016-11-21Clinical Trial Update: Study of BK1301 (DTaP Vaccine) as a Booster in Adolescents [Phase 3]
Phase 3 study of BK1301 DTaP vaccine booster in adolescents completed; results have been posted.
-
CLINICAL_TRIALS trial_result · 2016-11-04Clinical Trial Update: Immunogenicity and Safety of a DTPa-HBV-IPV/Hib Vaccine Given at 2, 3 and 4 Months of Age [Phase 2]
Phase 2 trial update evaluating the immunogenicity and safety of a pentavalent DTPa-HBV-IPV/Hib vaccine given at 2, 3, and 4 months of age.
-
CLINICAL_TRIALS trial_result · 2016-10-28Clinical Trial Update: Study to Assess Safety & Immunogenicity of GSK Biologicals' Boostrix (dTpa) Vaccine vs. Chinese DT Vaccine [Phase 3]
A Phase 3 trial comparing GSK Boostrix (dTpa) with a Chinese diphtheria-tetanus vaccine to assess safety and immunogenicity.
-
CLINICAL_TRIALS trial_result · 2016-10-27Clinical Trial Update: Study to Assess the Safety & Reactogenicity of GSK Biologicals' dTpa Vaccine (Boostrix) When Given at 6-8 Years of Age. [Phase 3]
A Phase 3 trial assessing the safety and reactogenicity of GSK's dTpa vaccine Boostrix when given to children aged 6-8 years; the study has …
-
CLINICAL_TRIALS trial_result · 2016-10-12Clinical Trial Update: Study to Assess the Safety & Reactogenicity of GSK Biologicals' DTPa/Hib Vaccine When Given at 3, 4 and 5 Months of Age [Phase 3]
A Phase 3 study assessing the safety and reactogenicity of GlaxoSmithKline's DTPa/Hib vaccine administered at 3, 4, and 5 months of age has …